PT Petrokimia Butadiene Indonesia (PBI), a Chandra Asri Petrochemical Group company, recently awarded CB&I a contract for the license and engineering design of three proprietary technologies in West Java, Indonesia.
The scope of work includes the license and engineering design of a CDMtbe® unit, a Butene-1 recovery unit and a BASF SELOP selective hydrogenation unit as part of an expansion of PBI's petrochemicals facilities.
Philip K. Asherman, CB&I's President and Chief Executive Officer, said: "This multi-technology contract underlines the confidence PBI has in our technology portfolio and further establishes our presence and leadership in the region."